Related Experiment Video

Updated: Aug 18, 2026

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
07:45

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor

Published on: June 27, 2011

Modulation of growth factor binding properties of alpha2-macroglobulin by enzyme therapy

D Lauer1, R Müller, C Cott

  • 1Institute of Biochemistry, University of Leipzig, Germany.

Cancer Chemotherapy and Pharmacology
|September 20, 2001
PubMed
Abstract

Insights

Oral proteinase treatment enhances alpha2-macroglobulin binding to transforming growth factor-beta (TGF-beta). This suggests proteinase therapy may reduce high TGF-beta levels, potentially aiding fibrosis and cancer treatment.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Immunology

Background:

  • Transforming growth factor-beta (TGF-beta) plays a role in fibrosis and cancer.
  • Alpha-2-macroglobulin (α2M) is a major protease inhibitor in plasma.
  • Understanding interactions between TGF-beta and α2M is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the binding of TGF-beta to human α2M after oral proteinase administration.
  • To explore the therapeutic potential of modulating TGF-beta levels via α2M.

Main Methods:

  • Volunteers received oral proteinases (trypsin, bromelain, rutoside) for 7 days.
  • Plasma TGF-beta binding to α2M was measured pre- and post-treatment using electrophoresis and gamma-counting.
  • In vitro cell culture experiments assessed the effect of transformed α2M on TGF-beta-induced fibroblast proliferation.

Main Results:

  • Oral proteinase intake induced α2M intermediates with high TGF-beta binding affinity.
  • Maximum TGF-beta binding occurred 1-2 hours post-ingestion.
  • Proteinase-α2M complexes inhibited TGF-beta's effect on fibroblast proliferation in vitro.

Conclusions:

  • Intestinal proteinase absorption triggers the formation of TGF-beta binding α2M species in blood.
  • This mechanism may facilitate TGF-beta clearance, reducing elevated levels.
  • Proteinase therapy shows promise for treating conditions with high TGF-beta, such as fibrosis and certain cancers.

More Related Videos

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: